An esophageal ulcer mimicking advanced esophageal cancer in a patient on alendronate sodium treatment for osteoporosis.
Terashima
T
T
Department of Internal Medicine, Toyama Prefectural Central Hospital, Toyama, Japan.
Hiramatsu
K
K
Shimatani
A
A
Matsuda
M
M
Ogino
H
H
Satomura
Y
Y
Noda
Y
Y
D019386:Alendronate / Q000009:adverse effects* / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004935:Esophageal Diseases / Q000139:chemically induced* / Q000175:diagnosis* / Q000473:pathology; D004938:Esophageal Neoplasms / Q000175:diagnosis*; D004945:Esophagoscopy; D005260:Female; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy; D014456:Ulcer / Q000139:chemically induced* / Q000175:diagnosis* / Q000473:pathology
D050071:Bone Density Conservation Agents; D019386:Alendronate